Wang David H sold $8.8M of ACMR

Wang David H (See Remarks) sold 100,002 shares of ACM Research, Inc. (ACMR) at an average of $88.35 ($83.86–$93.04, $8.84M total) across 11 trades over 2026-06-03 to 2026-06-04 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Wang David H
Published Jun 5, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 28, 2026, 3:46 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ACMR
Bearish
high confidence
Mentioned
$ACMR
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ACMRBearishLow
01

Why it matters

The disclosed sale reduces insider ownership and may influence short‑term price dynamics.

02

Market read

First‑report insider sell of $8.8M; modest but material for the stock, may trigger short‑term price pressure.

03

What to watch

No accompanying corporate news; the 10b5‑1 plan suggests pre‑planned execution, reducing informational asymmetry.

Relevance 5/10Novelty 7/10Timing: filed June 5, 2026 (same‑day filing)

Background

Form 4 filings disclose insider transactions and are primary sources for new insider activity.

Company-level read

Ticker impact

$ACMRBearishHigh confidence
Context

Officer/director sold $8.8M of shares via a 10b5‑1 plan, reducing his stake to 802,708 shares.

Expected impact

potential downward pressure as the market prices in the insider sale

Evidence & confidence

The sale size ($8.8M) is material for a mid‑cap biotech and was disclosed for the first time via a Form 4.

Market effects

May prompt scrutiny of insider activity in the biotech sector.

Limited to U.S. markets where ACMR trades.

Low; impact confined to the issuer and its investors.

Counterpoint

The sale could be a routine liquidity move, not a bearish signal.

Key entities

  • Wang David H

    10% owner of ACM Research who executed the sale.

  • ACM Research, Inc.

    Biotech equipment maker listed on NASDAQ under ACMR.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ACMRMed

Watch these Chinese chip stocks as U.S. tightens access to Nvidia hardware

The U.S. tightened restrictions on Chinese access to Nvidia chips, requiring licenses for shipments to certain countries and cloud access for Chinese firms. Chinese internet giants like Alibaba and Tencent fell, while domestic chipmakers such as SMIC, Cambricon, and NAURA rose. The market reaction reflects concerns over reduced access to advanced compute for AI developers and potential benefits for local chip suppliers.

$ACMRHighAI 8/10

ACM Research, Inc. Q3 2026 Earnings Call Summary

ACM Research reported Q3 2026 revenue growth of 37%, driven by market share gains and product innovation. Backlog reached $2.5 billion, up 88% YoY. Full-year 2026 revenue guidance was raised to $1.24B-$1.28B. Gross margin was 41.6%, slightly below target. The company expects growth in ECP, advanced packaging, and global customer revenue.

$ACMRHigh

ACM Research (ACMR) Q3 2026 Earnings Call Transcript

ACM Research reported Q3 2026 revenue of $368M, up 37%, with shipments up 31%. Growth was driven by ECP, advanced packaging, and cleaning categories. The company's backlog reached $2.5B, up 88% YoY. ACM highlighted market share gains, product cycle momentum, and technological advancements, including panel-level horizontal plating. Gross margin was 41.6%, and operating margin was 18%. The company remains optimistic about its growth prospects, particularly in China's WFE market.

$ACMRMedAI 8/10

ACM Research Q3 Earnings Call Highlights

ACM Research reported Q3 revenue of $109.5M, up 82.9%, driven by electrochemical plating. Advanced packaging revenue rose 71.2% to $47.5M. Gross margin was 41.6%, down from 42.1% YoY. Non-GAAP net income increased to $40.5M. The company expects growth in 2027 and is expanding internationally.

$ACMRHighAI 8/10

ACM Research Reports Third Quarter 2026 Results

ACM Research, Inc. (ACMR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 ACM Research Reports Third Quarter 2026 Results FREMONT, Calif., November 05, 2026(Globe Newswire) – ACM Research, Inc. (“ACM”) (NASDAQ: ACMR), a leading supplier of wafer processing solutions for semiconductor and advanced wafer-level packaging applications, today r